FUNCTIONAL-ACTIVITY OF MONOCLONAL-ANTIBODIES AGAINST LIPOPOLYSACCHARIDE (LPS) ANTIGENS OF GRAM-NEGATIVE BACILLI

被引：0
作者：
YOUNG, LS [1 ]
机构：
[1] UNIV CALIF LOS ANGELES,MED CTR,LOS ANGELES,CA 90024
来源：
CLINICAL RESEARCH | 1984年 / 32卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A518 / A518
页数：1
相关论文
共 50 条
[31]   ANTIENDOTOXIN MONOCLONAL-ANTIBODIES FOR GRAM-NEGATIVE SEPSIS - GUIDELINES FROM THE IDSA [J].
WENZEL, RP ;
ANDRIOLE, VT ;
BARTLETT, JG ;
BATT, MD ;
BULLOCK, WE ;
COBBS, CG ;
LIGHT, B ;
MARTIN, MA ;
SANFORD, J ;
SANDE, MA .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) :973-976
[32]   GRAM-NEGATIVE SEPSIS, THE SEPSIS SYNDROME, AND THE ROLE OF ANTIENDOTOXIN MONOCLONAL-ANTIBODIES [J].
BARRIERE, SL ;
GUGLIELMO, BJ .
CLINICAL PHARMACY, 1992, 11 (03) :223-235
[33]   MONOCLONAL-ANTIBODIES SPECIFIC FOR LIPID-A FROM GRAM-NEGATIVE BACTERIAS [J].
HARALDSON, L ;
FOLKER, AC ;
ELFMAN, L .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (02) :256-256
[34]   MONOCLONAL-ANTIBODIES AND SEPSIS BY GRAM-NEGATIVE GERMS - IS THEIR USE REALLY JUSTIFIED [J].
BADIA, X ;
SEGU, L ;
ALONSO, FG ;
ROVIRA, J .
MEDICINA CLINICA, 1993, 101 (07) :278-278
[35]   SHARED IDIOTYPES AMONG MONOCLONAL-ANTIBODIES SPECIFIC FOR DIFFERENT IMMUNODOMINANT SUGARS OF LIPOPOLYSACCHARIDE OF DIFFERENT GRAM-NEGATIVE BACTERIA [J].
HIERNAUX, J ;
BONA, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (05) :1616-1620
[36]   BACTERICIDAL ACTIVITY OF ETHANOL AGAINST GLUCOSE NONFERMENTATIVE GRAM-NEGATIVE BACILLI [J].
KOSHIRO, A ;
OIE, S .
MICROBIOS, 1984, 40 (159) :33-40
[37]   Current Activity of Ciprofloxacin Against Gram-Negative Bacilli in the United States [J].
C. Thornsberry ;
M. K. Marsilio ;
M. E. Jones ;
K. M. Tomfohrde ;
B. H. Heller ;
G. Piazza ;
Daniel F. Sahm .
Drugs, 1999, 58 :186-187
[38]   ANTIMICROBIAL ACTIVITY OF CARBENICILLIN/GENTAMICIN COMBINATION AGAINST GRAM-NEGATIVE BACILLI [J].
KLASTERSKY, J ;
SWINGS, G ;
DANEAU, D .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1970, 260 (06) :373-+
[39]   Current activity of ciprofloxacin against Gram-negative bacilli in the United States [J].
Thornsberry, C ;
Marsilio, MK ;
Jones, ME ;
Tomfohrde, KM ;
Heller, BH ;
Piazza, G ;
Sahm, DF .
DRUGS, 1999, 58 (Suppl 2) :186-187
[40]   Comparative in vitro activity of piperacillin/tazobactam against Gram-negative bacilli [J].
Liebowitz, LD ;
Klugman, KP .
SOUTH AFRICAN MEDICAL JOURNAL, 1996, 86 (10) :1276-1280
12345